trospium chloride


Also found in: Medical, Wikipedia.
Translations

trospium chloride

n cloruro de trospio
References in periodicals archive ?
The DDS, which releases the anticholinergic agent trospium chloride, can be applied into the bladder through the urethra.
Contract notice: "open house rebate contracts 2015-04" - complete non-exclusive discount agreements pursuant to A* 130a subsection 8 sgb v to the active ingredient trospium chloride (oral dosage forms) with anytime possibility of accession.
Specialist pharmaceutical company Watson Pharmaceuticals Inc (NYSE:WPI) reported on Friday the receipt of approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Trospium Chloride Extended-release Capsules.
Trospium chloride in patients with motor urge syndrome (detrusor instability): a double-blind, randomized, multicentre, placebo-controlled study.
For urge incontinence, your doctor may prescribe antispasmodic medications such as oxybutynin (Ditropan), tolterodine (Detrol), or trospium chloride (Sanctura), which relax muscles to help prevent episodes caused by urgency and frequency.
Five pharmacologic therapies have been approved for the treatment of OAB: oxybutynin, approved in immediate-release, extended-release, (11) and transdermal patch (12) formulations; immediate- and extended-release tolterodine (11); trospium chloride (13); solifenacin (14); and darifenacin.
Madaus has a varied product portfolio targeting urology, including proprietary products such as Trospium Chloride.
Compared with older anticholinergics approved for OAB, solifenacin is a more selective muscarinic receptor blocker, as is trospium chloride, Richard Bercik, M.
Trospium chloride versus oxybutynin: A randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia.
M2 EQUITYBITES-October 15, 2012-Watson Laboratories receives approval for Trospium Chloride Extended-release Capsules(C)2012 M2 COMMUNICATIONS http://www.
M2 PHARMA-October 15, 2012-Watson Laboratories receives approval for Trospium Chloride Extended-release Capsules(C)2012 M2 COMMUNICATIONS
Three antimuscarinic agents, solifenacin, trospium chloride, and darifenacin, have been studied in randomized, positively controlled clinical trials for their effects on the QT interval.